Radiopharmaceuticals Based on Ligands to Gastrin-Releasing Peptide Receptors: Current State of the Issue and Russian Developments
Data are presented on ligands based on bombesin derivatives, which are peptides that specifically bind to gastrin-releasing factor receptors, that are promising for use in nuclear medicine. An analysis of developments related to the creation of radiopharmaceuticals (RPs) based on gastrin-releasing p...
Gespeichert in:
Veröffentlicht in: | Nanobiotechnology Reports (Online) 2023-08, Vol.18 (4), p.643-649 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Data are presented on ligands based on bombesin derivatives, which are peptides that specifically bind to gastrin-releasing factor receptors, that are promising for use in nuclear medicine. An analysis of developments related to the creation of radiopharmaceuticals (RPs) based on gastrin-releasing peptide-receptor agonists for radionuclide diagnostics and systemic radiation therapy is carried out. The stages of pharmaceutical development of the first Russian RPs
68
Ga-NOTA-AMBA and
177
Lu-DOTA-AMBA are described, including the synthesis technology using automated modules, as well as drug specifications. |
---|---|
ISSN: | 2635-1676 1995-0780 2635-1684 1995-0799 |
DOI: | 10.1134/S2635167623600177 |